Ricerca avanzata

Home > Riviste > Minerva Urologica e Nefrologica > Fascicoli precedenti > Minerva Urologica e Nefrologica 2015 Settembre;67(3) > Minerva Urologica e Nefrologica 2015 Settembre;67(3):281-92

FASCICOLI E ARTICOLI   I PIÙ LETTI   eTOC

ULTIMO FASCICOLOMINERVA UROLOGICA E NEFROLOGICA

Rivista di Nefrologia e Urologia


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,536

 

Minerva Urologica e Nefrologica 2015 Settembre;67(3):281-92

HOT TOPICS IN PROSTATE CANCER 

 REVIEWS

Robot-assisted radical prostatectomy: recent advances

Mistretta F. A. 1, Grasso A. A. 1, Buffi N. 2, Cozzi G. 1, De Lorenzis E. 1, Fiori C. 3, Patel V. R. 4, Porpiglia F. 3, Scarpa R. M. 3, Srinivas S. 4, Rocco B. 1, 4

1 Department of Urology, University of Milan, Fondazione IRCCS Ca’ Granda-Ospedale Maggiore Policlinico, Milan, Italy;
2 Department of Urology, Istituto Clinico Humanitas, IRCCS Rozzano, Milan, Italy;
3 Department of Urology, San Luigi Hospital, University of Turin, Orbassano, Turin, Italy;
4 University of Central Florida School of Medicine and Global Robotics Institute, Florida Hospital-Celebration Health, Celebration, FL, USA

Robot assisted radical prostatectomy (RARP) represents the leading application of robotic surgery in the urologic field and it has become the main treatment option for localized prostate cancer (PCa) in the USA In the present review we summarized and critically analyzed the literature of the past five years about this widely used robotic procedure.
RARP has continuously evolved in terms of technical modifications and procedural steps. Long-term data are now available, suggesting comparable oncological outcomes to those of open and laparoscopic radical prostatectomy. Good functional outcomes have also been demonstrated.
Technological innovations and the introduction of more advanced robotic platforms featuring novel arm-integrated equipment, together with a mature clinical experience with the robotic approach, are likely to lead towards optimal outcomes.
Despite the expanding clinical implementation of RARP in the management of prostate cancer, some issues related to this procedure remain matter of debate, such as costs, comparative outcomes versus other approaches, and its role in high risk disease.

lingua: Inglese


FULL TEXT  ESTRATTI

inizio pagina